Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To analyze outcomes in patients who underwent liver transplantation (LT) for hepatocellular carcinoma (HCC) and received autologous intraoperative blood salvage (IBS).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): World J Gastrointest Surg

Title: World journal of gastrointestinal surgery

Publisher: Baishideng Publishing Group Inc.

ISSN: 1948-9366

Publication date (Electronic): Feb 27 2016

Volume: 8

Issue: 2

Affiliations

[1 ] Raphael LC Araujo, Liver Surgery Unit, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, CEP 05403-900, Brazil.

Article

DOI: 10.4240/wjgs.v8.i2.161

PMC ID: 4770170

PubMed ID: 26981190

SO-VID: 3368e34b-e0b7-4b7f-bf5e-5ffff769e36f

History

Keywords: Recurrence,Cancer,Cell saver,Hepatocellular carcinoma,Liver transplantation

Data availability:

Keywords: Recurrence, Cancer, Cell saver, Hepatocellular carcinoma, Liver transplantation

Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?

Read this article at

Abstract

Related collections

Karger: Oncology

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 9